Drug Profile
NEO 220
Alternative Names: NEO-220; Temozolomide-POH-linoleic acid; TMZ POH Linoleic acid; TMZ-POH-linoleic acidLatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator NEONC Technologies
- Class Antineoplastics
- Mechanism of Action Alkylating agents; Apoptosis stimulants; DNA synthesis inhibitors; Ras protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Cancer in USA (Cream)
- 30 Jul 2016 Early research in Cancer in USA (unspecified route)